JPRN-UMIN000022858尚未招募4 期
Investigation of satisfaction and efficacy after switching from daily DPP-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes -prospective observational study- - Study for the satisfaction and efficacy of trelagliptin
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patient with malignant tumor 2)Pregnancy, nursing woman or possibly pregnant woman 3)Patients with severe infection, pre or post operation, severe trauma 4)Patients who are taking kinds of steroid 5)Patients with severe liver dysfunction(AST,ALT>100U/L) 6) Type 1 diabetes mellitus 7) Patients with hypersensitivity to study drugs on this study 8)Patients who can not do diet and exercise therapy 9)Patients who thought to be inappropriate to enter this study for some reasons by physician's judgments
研究者
相似试验
进行中(未招募)
1 期
Subject reported outcomes on satisfaction, efficacy and safety with Luxerm® in the field-directed treatment of thin or non-hyperkeratotic and non-pigmented Actinic Keratosis of the face or the scalpThin or non-hyperkeratotic and non-pigmented Actinic Keratosis on the face and scalpMedDRA version: 19.1Level: HLTClassification code 10020648Term: HyperkeratosesSystem Organ Class: 100000004858EUCTR2017-000066-29-DEGalderma R&D50
招募中
2 期
Investigation of the effect of stromal vascular fraction on burn scarsBurn scars.Scar conditions and fibrosis of skinL90.5IRCT20210515051307N1Skin and Stem cell Research Center of Tehran University10
已完成
4 期
Evaluation of Satisfaction and Short-term Side effect after OsteoCalVitFort Practiceside effect of Calcium vitamin D.IRCT201312031414N30pharmedshayan pharmaceutical200
招募中
不适用
Outcome and patients’ satisfaction after functional treatment of acute lateral ankle injuries at emergency departments versus family doctor officesateral ankle injuriesLateral ankle injuriesSurgery - Other surgeryACTRN12608000246381niversity Hospital Bern100
已完成
4 期
Investigation of satisfaction, efficacy and safety after switching from daily GLP-1 receptor agonist to weekly dulaglutide in patients with type 2 diabetes -open label, randomized, parallel group controlled clinical studyType 2 diabetesJPRN-UMIN000024552Hokkaido University Graduate School32
